Alnylam Pharmaceuticals
ALNY
#554
Rank
โ‚น3.917 T
Marketcap
โ‚น29,535
Share price
-3.01%
Change (1 day)
29.79%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company